Handok Cash Flow Conversion Efficiency
Handok cash flow conversion efficiency. Based on the latest financial reports, Handok (002390) has a cash flow conversion efficiency ratio of 0.001x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩154.83 Million ≈ $104.93K USD) by net assets (₩267.90 Billion ≈ $181.56 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Handok (2011–2025)
Cash flow conversion efficiency of Handok from 2011 to 2025. This chart illustrates how Handok's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Handok (002390) share price today for real-time trading data and today's change.
Handok Cash Flow Conversion Ratio Explained
Handok cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Handok Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Handok ranked by their cash flow conversion efficiency. Also see 002390 stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Lautan Luas Tbk
JK:LTLS
|
-0.027x |
|
Adtraction Group AB
ST:ADTR
|
0.055x |
|
Europap Tezol Kagit Sanayi Ve Ticaret AS
IS:TEZOL
|
0.105x |
|
Jeil Pharm
KO:002620
|
-0.010x |
|
Incheon City G
KO:034590
|
-0.098x |
|
Minaurum Silver Inc.
V:MGG
|
-0.431x |
|
Eaton Vance California MIT
NYSE MKT:CEV
|
0.018x |
|
Bank Victoria International
JK:BVIC
|
0.016x |
Annual Cash Flow Conversion Efficiency for Handok (2011–2025)
The table below shows the annual cash flow conversion efficiency of Handok from 2011 to 2025. Review Handok free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩278.32 Billion ≈ $188.61 Million |
₩3.98 Billion ≈ $2.70 Million |
0.014x | +248.38% |
| 2024-12-31 | ₩289.06 Billion ≈ $195.89 Million |
₩-2.79 Billion ≈ $-1.89 Million |
-0.010x | -109.13% |
| 2023-12-31 | ₩340.63 Billion ≈ $230.84 Million |
₩35.98 Billion ≈ $24.38 Million |
0.106x | +32.15% |
| 2022-12-31 | ₩381.86 Billion ≈ $258.78 Million |
₩30.52 Billion ≈ $20.68 Million |
0.080x | -17.56% |
| 2021-12-31 | ₩384.00 Billion ≈ $260.23 Million |
₩37.23 Billion ≈ $25.23 Million |
0.097x | +52.09% |
| 2020-12-31 | ₩381.85 Billion ≈ $258.77 Million |
₩24.34 Billion ≈ $16.50 Million |
0.064x | +149.23% |
| 2019-12-31 | ₩343.99 Billion ≈ $233.12 Million |
₩8.80 Billion ≈ $5.96 Million |
0.026x | -72.79% |
| 2018-12-31 | ₩313.38 Billion ≈ $212.37 Million |
₩29.46 Billion ≈ $19.96 Million |
0.094x | +302.39% |
| 2017-12-31 | ₩290.71 Billion ≈ $197.01 Million |
₩6.79 Billion ≈ $4.60 Million |
0.023x | +179.47% |
| 2016-12-31 | ₩289.25 Billion ≈ $196.02 Million |
₩-8.50 Billion ≈ $-5.76 Million |
-0.029x | -160.97% |
| 2015-12-31 | ₩303.71 Billion ≈ $205.82 Million |
₩14.64 Billion ≈ $9.92 Million |
0.048x | -59.42% |
| 2014-12-31 | ₩307.77 Billion ≈ $208.57 Million |
₩36.56 Billion ≈ $24.78 Million |
0.119x | +276.75% |
| 2013-12-31 | ₩294.28 Billion ≈ $199.43 Million |
₩9.28 Billion ≈ $6.29 Million |
0.032x | -26.21% |
| 2012-12-31 | ₩287.25 Billion ≈ $194.67 Million |
₩12.28 Billion ≈ $8.32 Million |
0.043x | -75.26% |
| 2011-12-31 | ₩278.34 Billion ≈ $188.62 Million |
₩48.08 Billion ≈ $32.59 Million |
0.173x | -- |
About Handok
HANDOK Inc. operates as a pharmaceutical company. The company provides prescription and OTC drugs; medical devices, such as blood pressure monitors, cholesterol monitoring systems, insulin pumps, self-monitoring system of blood glucose, and blood glucose monitoring system; in vitro diagnostic medical devices; as well as life science products. It also offers healthcare products comprising food sup… Read more